These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3334109)

  • 21. The upper gastrointestinal safety of rofecoxib vs. NSAIDs: an updated combined analysis.
    Watson DJ; Yu Q; Bolognese JA; Reicin AS; Simon TJ
    Curr Med Res Opin; 2004 Oct; 20(10):1539-48. PubMed ID: 15462687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biliary excretion of radiochromium.
    De Médicis R; LeBel E; Rioux A; Navert H; Lamoureux G; Tetreault L; Lussier A
    Am J Med; 1988 Aug; 85(2):276. PubMed ID: 3261133
    [No Abstract]   [Full Text] [Related]  

  • 23. Etodolac, aspirin, and gastrointestinal microbleeding.
    Arnold JD; Mullane JF; Hayden DM; March L; Hart K; Perdomo CA; Fencik M; Berger AE
    Clin Pharmacol Ther; 1984 May; 35(5):716-21. PubMed ID: 6232035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
    Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ
    N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.
    Lanas A; Bajador E; Serrano P; Fuentes J; Carreño S; Guardia J; Sanz M; Montoro M; Sáinz R
    N Engl J Med; 2000 Sep; 343(12):834-9. PubMed ID: 10995862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
    Langman MJ; Jensen DM; Watson DJ; Harper SE; Zhao PL; Quan H; Bolognese JA; Simon TJ
    JAMA; 1999 Nov; 282(20):1929-33. PubMed ID: 10580458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time course and pattern of blood loss with ibuprofen treatment in healthy subjects.
    Bowen B; Yuan Y; James C; Rashid F; Hunt RH
    Clin Gastroenterol Hepatol; 2005 Nov; 3(11):1075-82. PubMed ID: 16271337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of non-steroidal anti-inflammatory drugs: what are the connections?
    McCarthy DM
    Eur J Surg Suppl; 2002; (587):89-99. PubMed ID: 16144207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of low-dose misoprostol and naproxen vs. nabumetone to prevent recurrent upper gastrointestinal haemorrhage in users of non-steroidal anti-inflammatory drugs.
    Chan FK; Sung JJ; Ching JY; Wu JC; Lee YT; Leung WK; Hui Y; Chan LY; Lai AC; Chung SC
    Aliment Pharmacol Ther; 2001 Jan; 15(1):19-24. PubMed ID: 11136274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of etodolac SR and naproxen on gastro-intestinal blood loss.
    Leese P
    Curr Med Res Opin; 1992; 13(1):13-20. PubMed ID: 1468240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials.
    Salvo F; Fourrier-Réglat A; Bazin F; Robinson P; Riera-Guardia N; Haag M; Caputi AP; Moore N; Sturkenboom MC; Pariente A;
    Clin Pharmacol Ther; 2011 Jun; 89(6):855-66. PubMed ID: 21471964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gastrointestinal bleeding induced by nonsteroidal antiinflammatory drugs].
    Shostak NA; Aksenova AV; Riabkova AA; Fedorov ED; Maliarova LP; Krutova TA; Dunaeva IuV; Ivanov DS; Kazakova TV
    Ter Arkh; 2000; 72(5):60-1. PubMed ID: 11109625
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical aspects of upper gastrointestinal bleeding associated with the use of nonsteroidal antiinflammatory drugs.
    László A; Kelly JP; Kaufman DE; Sheehan JE; Rétsági G; Wiholm BE; Koff RS; Sundström A; Shapiro S
    Am J Gastroenterol; 1998 May; 93(5):721-5. PubMed ID: 9625116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
    Biskupiak JE; Brixner DI; Howard K; Oderda GM
    J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
    Chan FK; Abraham NS; Scheiman JM; Laine L;
    Am J Gastroenterol; 2008 Nov; 103(11):2908-18. PubMed ID: 18853980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding.
    Blot WJ; McLaughlin JK
    J Epidemiol Biostat; 2000; 5(2):137-42. PubMed ID: 10890286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal blood loss during treatment with naproxen for rheumatoid arthritis.
    van den Ouweland FA; Corstens FH; van de Putte LB; Gribnau FW
    Scand J Rheumatol; 1987; 16(5):365-70. PubMed ID: 3500510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of hospitalization with peptic ulcer disease or gastrointestinal hemorrhage associated with nabumetone, Arthrotec, diclofenac, and naproxen in a population based cohort study.
    Ashworth NL; Peloso PM; Muhajarine N; Stang M
    J Rheumatol; 2005 Nov; 32(11):2212-7. PubMed ID: 16265705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E; Nedjar H
    Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nonvariceal upper gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drugs in Metropolitan Lima].
    Salvatierra Laytén G; de la Cruz Romero L; Paulino Merino M; Vidal Vidal V; Rivera Dávila C; Cano Chuquilin A; Frisancho Velarde O
    Rev Gastroenterol Peru; 2006; 26(1):13-20. PubMed ID: 16622483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.